Introduction
Arsenic compounds have been regarded as comutagens and cocarcinogens by epidemiological studies, 1 but been used historically to treat patients with acute leukemia and chronic myelogenous leukemia (CML). 2 Recently arsenic trioxide (As 2 O 3 ) has shown a high and specific effect on acute promyelocytic leukemia (APL). 3, 4 The Shanghai group reported that As 2 O 3 induced complete remission in 66-84% of patients with APL and could trigger apoptosis of APL cell line cells (NB4), which was associated with down-regulation of bcl-2 expression and with modulation of PML-RAR␣ chimeric protein. As 2 O 3 exerted dose-dependent dual effects, triggering apoptosis at higher concentrations and inducing partial differentiation at lower concentrations, probably as a result of the degradation of PML-RAR␣ protein. 5, 6 As 2 O 3 also showed cytotoxic effect on acute myeloid leukemia (AML) cells, although the effect was not strong in those cells. 7, 8 With regard to neoplastic lymphoid cells, organic arsenical melarsoprol reportedly induced apoptosis in chronic lymphocytic leukemia (CLL) cells and CLL cell lines at a lower concentration of 0.1 mol/l, while As 2 O 3 was not effective on APL cells and CLL cells at this concentration. 9 In the present study, we tested As 2 O 3 on lymphoid lineage cells at various concentrations, and found that 1 mol/l As 2 O 3 induced apoptosis and downCorrespondence: K Ohnishi; Fax: 81 53 434 2910 Received 17 March 1998; accepted 6 May 1998 regulated bcl-2 in some neoplastic lymphoid cells, and that it induced no apoptosis but caused cell cycle arrest in EpsteinBarr virus (EBV) transformed lymphoid cell lines.
Materials and methods

Reagents
As 2 O 3 (Sigma, St Louis, MO, USA) was dissolved in ammonium hydroxide (Sigma). A stock solution was made at the concentration of 20 mol/l and diluted to working concentrations (0.1-2 mol/l) by RPMI 1640 (GIBCO, Grand Island, NY, USA) before use.
Cell lines
Three human leukemia cell lines and four human lymphoma cell lines were used in this study. HL-60 was derived from a patient with acute myeloid leukemia (FAB M2), 10 and NB4 from APL (FAB M3) 11 and NKM-1 from acute myeloid leukemia (FAB M2).
12 NOL-3 was established from pleural effusion of a patient with B cell non-Hodgkin's lymphoma, diffuse large cell type. 13 NOP-1 was established from the bone marrow of a patient with multiple myeloma (IgA, type).
14 The human EBV-positive lymphoma cell lines, Raji 15 and Daudi, 16 were obtained from the American Type Culture Collection (Rockville, MD, USA). All cell lines were cultured in RPMI 1640, supplemented with 1% penicillin/streptomycin, 1 mmol/l L-glutamine and 10% heat-inactivated fetal bovine serum (FBS; GIBCO), at 37°C in a 5% CO 2 humidified atmosphere.
Patient samples
After informed consent, heparinized peripheral blood was obtained from five patients with CLL, and from three patients with non-Hodgkin's lymphoma (NHL; one diffuse small B cell type, one Burkitt type and one diffuse large B cell type), whose peripheral blood contained over 90% of lymphoma cells. Normal heparinized peripheral blood was obtained from five healthy volunteers. Peripheral blood mononuclear cells were isolated by the Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden) density-gradient centrifugation, and incubated in plastic culture dishes in RPMI 1640 with 10% FBS for 1 h. The non-adherent cells were collected and adjusted at 5 × 10 5 cells/ml.
Cell viability and proliferation assay
Cell viability and proliferation were assessed by trypan blue dye exclusion assay. Cells were mixed with an equal volume of PBS containing 0.4% trypan blue dye, and manually counted in triplicate. Cell viability and proliferation were also measured with MTT assay as described by Mosmann 17 with a slight modification. After incubation in 0.1 ml of the medium for 3 days, 10 l (5 mg/ml) MTT salt (Sigma) was added to each well and plates were incubated at 37°C for 4 h. Onehundred l of acid-isopropanol (0.04 N HCl in isopropanol) was added to each well and mixed by pipetting to dissolve the reduced MTT formazans, and the relative cell viability was measured by scanning with an ELISA reader with a 570 nm filter. The effect of drug on growth inhibition could be assessed as follows: inhibition of cell proliferation (%) = (1 − mean OD value of treated cell/mean OD value of control wells) × 100%.
Flow cytometric analysis of apoptosis and cell cycle distribution
Apoptosis was identified and quantified by flow cytometry with propidium iodide (PI; Sigma) staining. 18 Cells (10 5 ) were washed twice with phosphate-buffered saline (PBS) and incubated in 70% methanol on ice. After 30-min incubation, cells were washed twice with PBS, and then 70 l of RNase A (1 mg/ml; Sigma) and 140 l of PI (50 mg/ml) solution were added to each sample. After 1-h incubation in the dark, DNA analysis was done using EPICS Profile II (Coulter Corp, Hialeah, FL, USA). Apoptosis was quantified by measuring signals in the hypodiploid region. 18 On cell cycle analysis, the relative number of cells in the different phases were assessed by Multicycle software (Phoenix, San Diego, CA, USA), and the percentages of cells calculated in G 0 /G 1 , S and G 2 /M phases of the cell cycle.
Morphological assessment of apoptosis
Cells (2 × 10 4 ) were spun down on to microslide glasses by cytospin (Shandon, Pittsburgh, PA, USA) and then stained with May-Grü nwald-Giemsa staining. Apoptotic cells were morphologically identified by cellular and nuclear shrinkage, cytoplasmic blebbing, nuclear and cytoplasmic fragmentation, and formation of apoptotic body.
DNA fragmentation assay
Apoptosis was also confirmed by detection of fragmentation of chromosomal DNA as the classic DNA ladder by a modified method of Sellins and Cohen. 19 Briefly, cells (2 × 10 6 ) were immersed in cytolysis buffer consisting of 100 l of 100 mmol/l Tris-HCl (pH 7.4), 10 mmol/l EDTA and 0.5% Triton X-100. The mixture was treated with 400 g/ml RNase A (Sigma) and then with 400 g/ml proteinase K (Sigma). DNA was extracted with phenol-chloroform, precipitated with isopropylalcohol, dissolved in 10 l of 10 mmol/l Tris-HCl (pH 7.4) and 1 mmol/l EDTA, and separated in 2% agarose gels. DNA was visualized by staining with ethidium bromide.
Flow cytometric analysis of bcl-2 protein
The expression of bcl-2 protein was analyzed by flow cytometry. 20 Cells were suspended in PBS at 2 × 10 7
/ml, and cell fixation and permeabilization were performed using 70% methanol for 1 h. After blocking by incubation with normal goat serum for 15 min, 10 6 cells were incubated with anti-bcl-2 monoclonal antibody labeled with FITC (DAKO, Glostrup, Denmark) at 4°C for 30 min. FITC-conjugated irrelevant mouse IgG1 was used as a negative control to determine background fluorescence. After washing three times with PBS, they were analyzed in an EPICS Profile II (Coulter Corp), and the expression of bcl-2 was determined by the mean fluorescence intensity.
Statistical analysis
Results were expressed as mean ± standard deviation (s.d.). Statistical significance (P Ͻ 0.05) was assessed using the Student's t-test.
Results
Effect of As 2 O 3 on proliferation and viability
Cells (2 × 10 5 ) were incubated with various concentration of As 2 O 3 in 1 ml of RPMI 1640 with 10% FBS for 5 days, and proliferation and viability were evaluated by the trypan blue dye exclusion test. In NOP-1 and NOL-3 cells, As 2 O 3 reduced both proliferation and viability time-and dose-dependently at 1 and 2 mol/l; while, in Raji and Daudi cells, As 2 O 3 inhibited proliferation but had little effect on viability at 1 and 2 mol/l (Figure 1) . In NB4 and NKM-1 cell lines, As 2 O 3 reduced both proliferation and viability at 1 and 2 mol/l, but in HL-60, it inhibited proliferation alone and had little effect on viability (Figure 2) . In normal PBL, CLL cells and NHL cells, although these cells did not proliferate in the culture condition used, As 2 O 3 reduced survival and viability at 1 and 2 mol/l (Figure 3) .
To confirm the above findings, proliferation and survival of cells were evaluated by the MTT assay after incubation with 1 and 0.1 mol/l As 2 O 3 for 3 days. The results of MTT assay showed almost the same inhibitory effect of As 2 O 3 as trypan blue dye exclusion test in high concentration (1 mol/l) ( Figure 4) ; while, at lower concentration (0.1 mol/l), viable cell number counted by trypan blue dye exclusion test showed no effect, but MTT assay showed higher activity of MTT dye conversion in all cell lines except NB4 ( Figure 5 ).
Induction of apoptosis by As 2 O 3
We first studied the morphology of cells treated with As 2 O 3 . As shown in Figure 6 , NOP-1 and NKM-1 cells treated with 1 mol/l As 2 O 3 for 3 days showed typical apoptotic features, including cellular shrinkage, chromatin condensation and nuclear fragmentation. Apoptotic cell death was also assessed by flowcytometry with PI staining on day 3. As shown in Figure 7 , the mean percentage of apoptotic cells was 61% in NB4, 29% in NKM-1, 46% in NOP-1 and 10% in NOL-3 after the treatment of 1 mol/l As 2 O 3 for 3 days, while the percentage of apoptotic cells in Daudi, Raji and HL-60 cell lines was lower than 10%. Apoptosis was also observed in normal PBL (23%), NHL cells (23%) and CLL cells (32%) after being treated with 1 mol/l As 2 O 3 for 3 days. Apoptosis in those cells was confirmed by a ladder of fragmented DNA. Figure  8 showed DNA ladder formation in NOP-1 cells treated with As 2 O 3 . The DNA ladder was apparently induced by 1 and 2 mol/l As 2 O 3 . On the other hand, Raji, Daudi and HL-60 cells did not show any significant apoptosis in either morphology, DNA degradation or PI-stained flowcytometry during up to 5-day treatment with 0.1-2 mol/l As 2 O 3 . To clarify the mechanism of growth inhibition by As 2 O 3 on HL-60, Raji and Daudi cells, which showed little apoptosis, we measured the cell cycle distribution of these cells incubated with 1 mol/l As 2 O 3 for 5 days. As shown in Table 1 , the S phase fraction decreased and the G 0 /G 1 fraction increased on day 3 and day 5, indicating that these cells were arrested at the G 0 /G 1 phase. 
Modulation of bcl-2 protein expression by As
The expression of bcl-2 protein was examined by flow cytometry (Table 2) . Bcl-2 protein was significantly (P Ͻ 0.05) reduced after 3-day culture with 1 mol/l As 2 O 3 in NB4, NKM-1 and NOP-1, and these cells showed apparent apoptosis after As 2 O 3 treatment; while, in HL-60, NOL-3, Raji and Daudi cells, bcl-2 protein expression was not changed and little apoptosis was observed with 1 mol/l As 2 O 3 . In normal PBL and CLL cells, bcl-2 protein expression was significantly decreased after As 2 O 3 treatment. As for NHL cells, no conclusion could be reached due to an insufficient statistic population, but we can still observe that the expression was slightly decreased after As 2 O 3 treatment. Thus, down-regulation of bcl-2 protein expression was well correlated with the induction of apoptosis. 
Figure 5
Effect of low concentration As 2 O 3 (0.1 mol/l) on cell lines tested by MTT assay. After incubation with 0.1 mol/l As 2 O 3 for 3 days, MTT assay was carried out and the inhibition was calculated as follows: % Inhibition = (1 − mean OD of treated cells/mean OD of control wells) × 100%. Each value is the mean of three or more independent experiments ± s.d.
Discussion
In the present study, we demonstrated that As 2 O 3 inhibited dose-dependently the proliferation of myeloid and lymphoid culture cell lines but showed different effects on viability of these cells. As 2 O 3 at a concentration of 1 mol/l induced apoptosis in myeloid and lymphoid cell lines such as NB4, NKM-1 and NOP-1. The induction of apoptosis was associated with the down-regulation of bcl-2 protein expression. However, in HL-60, Daudi and Raji cells, 1 mol/l As 2 O 3 inhibited the proliferation of cells but induced a little apoptosis. In these cells, the proportion of G 1 cells increased with the decrease of cells in S phase. This implies that As 2 O 3 arrested those cells in G 1 phase. As 2 O 3 at a lower concentration (0.1 mol/l) showed higher activity of MTT dye conversion in cell lines except for NB4, although the number of cells did not increase by the As 2 O 3 treatment. MTT assay is reportedly for assaying cell survival and proliferation. MTT is cleaved in active mitochondria, so the reaction occurs only in living cells, and activated cells produce more formazan than resting cells, which could allow the measurement of activation even in the absence of proliferation. 17 Therefore, low In China, the arsenic compounds have been used in the treatment of APL since the 1970s, and have achieved good complete remission rate and long-term survival. 3 Recently, it has been reported that As 2 O 3 specifically induced apoptosis in NB4 and APL cells. In NB4 cells, As 2 O 3 down-regulated the bcl-2 expression at the mRNA and protein level, but showed no influence on the expression of p53 and c-myc genes. 4 In non-APL cells, As 2 O 3 reportedly induced the targeting of the nucleoplasmic fraction of PML on to the matrixbound nuclear body, where PML was degraded, but in APL cells, PML and PML/RAR␣ were both relocalized and degraded by As 2 O 3 . The mechanism of PML/RAR␣ degradation by all-trans retinoic acid (RA) and As 2 O 3 are likely different. 21 With RA, a specific cleavage product of the fusion is generated that may retain some transcriptional activation properties. Thus, RA and arsenic seem to target RAR␣ and PML, respectively, and induce the degradation of the fusion protein. 21 These findings suggest that As 2 O 3 induces apoptosis most effectively in NB4 and APL cells which express PML/RAR␣ fusion protein.
However, As 2 O 3 also induced apoptosis in neoplastic lymphoid cells which accompanied the down-regulation of bcl-2 expression. Kö nig et al 9 reported that organic arsenical, melarsoprol but not As 2 O 3 , induced apoptosis in CLL cell lines and was associated with down-regulation of bcl-2 protein expression. Some other findings on arsenic compounds and hematological neoplasms except APL have been reported at recent meetings. Organic arsenical, melarsoprol, showed a broad activity on a variety of leukemia cell lines including lymphoid leukemia 7 and myeloma cell lines, 22 and As 2 O 3 at 1 mol/l also showed cytotoxic effects on non-M3 AML 23 and ATL cell lines. 24 The optimal concentration of As 2 O 3 to induce apoptosis in lymphoid cells was 0.5-2 mol/l in our study and the same concentration was optimal in APL. 4 There have been 
Figure 8
Agarose gel electrophoresis analysis of DNA fragmentation in NOP-1 cells treated with As 2 O 3 for 3 days. Lane 1, untreated control; lanes 2-5, treated with 2, 1, 0.5 and 0.1 mol/l As 2 O 3 , respectively. no other published data on the cytotoxic effect of As 2 O 3 on low-grade lymphoid neoplasms (CLL, low-grade lymphoma and myeloma) at the same concentrations in APL cells (1-2 mol/l). These findings suggest that down-regulation of bcl-2 protein may be one of the mechanisms in the induction of apoptosis with As 2 O 3 . Cellular ATP level was also considered to be related to apoptosis. Arsenic compounds, which can induce ATP depletion in mitochondria, 25 may also initiate apoptosis through decreasing cellular ATP level. It is well known that As 2 O 3 can modulate some enzyme activity by combination with −SH group of amino acid. The arsenic can also interfere with the phosphorylation-dephosphorylation process by replacing the phosphate. 8, 26 In the present study, As 2 O 3 induced no apoptosis in Raji, Daudi and HL-60 cells, but inhibited the cell proliferation, while it did not decrease the cell viability. The cell cycle distribution in those cell lines indicated that cells were arrested in G 1 phase. On the other hand, As 2 O 3 induced apoptosis in cells which accompanied the down-regulation of bcl-2 expression. These findings suggested that regulating genes such as bcl-2 may play a more important role in the induction of apoptosis by As 2 O 3 .
It was reported that effect of arsenic on DNA synthesis in human lymphocytes stimulated by PHA were biphasic: As 2 O 3 at very low concentration enhanced DNA synthesis, whereas As 2 O 3 at high concentration inhibited DNA synthesis. 27 Kö nig et al 9 reported that melarsoprol at a low concentration of 0.001-0.1 mol/l caused a dose-and time-dependent inhibition of survival and growth in lymphoid cell lines, but that, in contrast, As 2 O 3 at similar concentrations had no effect. We also found that As 2 O 3 at a low concentration (0.1 mol/l) rather stimulated leukemia cells except NB4. However, As 2 O 3 had an apparent inhibitory effect on survival or proliferation of cells when used at a concentration of 1 mol/l, which supposedly is an effective plasma concentration of arsenic (0.5-2 mol/l) in the treatment of APL.
In conclusion, the present study shows that As 2 O 3 could inhibit leukemia and lymphoma cell proliferation by induction of cell apoptosis or by cell cycle arrest. The effect on lymphoid neoplasms has shown that it can be used not only in APL treatment but in other lymphoid neoplasms that are refractory to conventional therapy.
